This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) advanced 1.90% to $427.71 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.45% to 15,037.76 and Dow Jones Industrial Average falling 0.84% to 34,577.57. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $69.78 below its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 0.93% to $106.48, Amgen Inc. (AMGN) fell 0.31% to $216.04, and AstraZeneca PLC ADR (AZN.LN) remained unchanged. Trading volume (14.7 M) remained 5.4 million below its 50-day average volume of 20.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2021.
(END) Dow Jones Newswires
September 14, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.